Page last updated: 2024-09-05

dabigatran and B-Cell Chronic Lymphocytic Leukemia

dabigatran has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Falbo, M; Iannaccaro, P; Levato, L; Prejanò, S; Santoro, RC	1

Other Studies

1 other study(ies) available for dabigatran and B-Cell Chronic Lymphocytic Leukemia

Article	Year
Dabigatran in ibrutinib-treated patients with atrial fibrillation and chronic lymphocytic leukemia: experience of three cases. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2021, Mar-01, Volume: 32, Issue:2 Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors	2021

Article

Year

Dabigatran in ibrutinib-treated patients with atrial fibrillation and chronic lymphocytic leukemia: experience of three cases.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2021, Mar-01, Volume: 32, Issue:2

Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors

2021